Take home Earlier today (23 May 2007), a unanimous Australian High Court handed down the long-awaited decision in the Lockwood v Doric patent dispute. For those who aren’t patent lawyers –...
On 30 April 2007, the US Supreme Court handed down its long awaited decision in Microsoft v AT&T. It’s usually safe to assume that because IP rights must be granted by...
On 30 April 2007, the US Supreme Court handed down its long awaited (and unanimous) decision in KSR v Teleflex. Lawyers love bullet point tests that they can apply when advising...
How confident are you that your next product launch or commercial innovation does not infringe anyone else’s intellectual property rights? The fact that you’re reading this article suggests that you are...
In a predictable blow to those wanting to decrease the costs of international intellectual property litigation, the US Court of Appeals for the Federal Circuit delivered its long-awaited judgment in Voda...
The Zyprexa case is a timely reminder that in IP Strategy, a simple rule of thumb, though useful, is almost always inadequate. Zyprexa underscores the point that infringement and novelty are...
The first-instance judgment in the Australian part of the global Lipitor patent dispute was handed down earlier today (20 December 2006). Click here to go to the judgment. In essence, as...
This one’s succinct but very important for those interested in the interplay between IP strategy and government regulatory control or pharmaceuticals in the USA. The broad take-home is — if government...
In my earlier article ‘Analysing IP — put simply’, I introduced the ‘6T’™ framework for analysing IP issues. This article uses the same framework to show you how to simply structure...
Please use the link to the oxford site to view this article
You must be logged in to post a comment.